Gilead Sciences Inc (GILD) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Gilead Sciences Inc (US:GILD), trading at 131.28. In 2025, Gilead Sciences Inc generated $29.44 Billion in revenue and $9.46 Billion in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Gilead Sciences Inc is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 131.28
- Recent Revenue (2025): $29.44 Billion
- Free Cash Flow (2025): $9.46 Billion
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.